Pediatric Rheumatology

Article	Citations
Predictors of fibrogenesis in children with JIA: a single-center pilot study	185
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial	44
Algorithmic approach in the diagnosis of pediatric uveitis	43
Clinical features, treatment, and outcomes of celiac-associated arthritis: a retrospective cohort study	37
The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource	37
Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis	31
Developmentally appropriate transitional care during the Covid-19 pandemic for young people with juvenile-onset rheumatic and musculoskeletal diseases: the rationale for a position statement	26
The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis	25
Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC)	24
Predictive value of Albumin-Bilirubin grade for intravenous immunoglobulin resistance in a large cohort of patients with Kawasaki disease: a prospective study	24
Serositis as an indicator of poor prognosis in pediatric systemic lupus erythematosus	24
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives	22
Musculoskeletal symptoms and their impact on health-related quality of life in chronic nonbacterial osteomyelitis patients	22
Experiences of sexual and reproductive health screening and counseling in the clinical setting among adolescents and young adults with rheumatic disease	22
Juvenile dermatomyositis: association between nail fold capillary end row loop– area under the curve– and disease damage indicators	21
Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience	20
Therapeutic recreation camps for youth with childhood-onset systemic lupus erythematosus: perceived psychosocial benefits	20
Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study	18
Proceedings of the 29th European Paediatric Rheumatology Congress	18
Natural autoimmunity in oligoarticular juvenile idiopathic arthritis	18
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication	17
Relationship of regional ultraviolet index data with rash and systemic disease activity in youth with childhood-onset systemic lupus: results from the Childhood Arthritis and Rheumatology Research All	17
Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort	16
A randomized controlled educational study to evaluate an e-learning module to teach the physical examination of the temporomandibular joint in juvenile idiopathic arthritis	16
The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patients	16

Frequency of remission achievement in the pre-treat-to-target decade in juvenile idiopathic arthritis	16
Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals	16
Pediatric immune-mediated necrotizing myopathy with anti-SRP antibodies targeting 19, 68, and 72 kda subunits	15
Investigating the association between SARS-CoV-2 infection, COVID-19 vaccination, and autoimmune diseases in a pediatric population: a comprehensive analysis	15
Clinical and genetic characteristics of PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome	14
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge	14
Correction: PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	14
Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort study	14
Myeloid-related protein 8/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center	14
Translating research into practice—implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retr	14
Body mass index is associated with health-related quality of life and disease characteristics in young adults with juvenile idiopathic arthritis	14
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the “comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS” (S	14
Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis	14
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study	14
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis	13
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice	13
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report	13
How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience	13
Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry	13
Identification of a variant in NLRP3 gene in a patient with Muckle-Wells syndrome: a case report and review of literature	13
Exploring paediatric rheumatology care: a ten-year retrospective analysis of the patient population in Ghana	13
14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report	13
Cytokines in saliva, serum, and temporomandibular joint synovial fluid in children with juvenile idiopathic arthritis: An explorative cross-sectional study	13
Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis	13
Circulating prolactin level in Juvenile Systemic Lupus Erythematosus and its correlation with disease activity: a case control study	12
Exploring the clinical profiles and management of juvenile dermatomyositis in Africa: a survey of African rheumatology care providers	12
Feasibility of quantitative sensory testing in juvenile idiopathic arthritis	12
Long noncoding RNAs (CTC-471J1.2, NeST) as epigenetic risk factors of active juvenile lupus nephritis: a case-control study	12
Differences between leukemic arthritis and juvenile idiopathic arthritis	11
Tapering of biological treatment in autoinflammatory diseases: a scoping review	11
An iceberg I can’t handle: a qualitative inquiry on perceptions towards paediatric rheumatology among healthcare workers in Kenya	11
Longitudinal assessment of preparation for care transition among adolescents and young adults with rheumatologic disease: a single-center pilot study	11
Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature review	11
Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases	11
Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report	11
Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis	11
Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort	11
Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysis	11
NLRP12-associated systemic autoinflammatory diseases in children	11
Screening for celiac disease in juvenile idiopathic arthritis	11
A novel PRKDC mutation caused B lymphocytes V(D)J rearrangement disorder in the SLE-DAH like symptoms patient	10
Chronic non-bacterial osteomyelitis in children- five-year standardized follow-up of a prospective observational cohort in the pre-biological era	10
Epstein–Barr Virus encephalitis associated hemophagocytic lymphohistiocytosis in childhood-onset systemic lupus erythematosus: a case-based review	10
Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance	10
Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms	10
A virtual pediatric rheumatology teaching initiative for physicians in Somaliland	10
Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review	10
Monogenic disorders as mimics of juvenile idiopathic arthritis	10
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis	9
Structural ultrasound of joints and tendons in healthy children: development of normative data	9

Management of childhood-onset systemic lupus erythematosus (cSLE) over the last two decades in Spain	9
Depression and anxiety in childhood-onset systemic lupus erythematosus: prevalence, associated factors, and impact on quality of life and family	9
Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases	9
Hypertension as a prominent manifestation secondary to renal artery lesions in pediatric Behcet’s disease	9
A qualitative evaluation of the specific carbohydrate diet for juvenile idiopathic arthritis based on children’s and parents’ experiences	9
Correction: Transition readiness among finnish adolescents with juvenile idiopathic arthritis	9
Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study	9
Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients	9
Restricted upper airway dimensions in patients with dentofacial deformity from juvenile idiopathic arthritis	9
Kawasaki disease in Kenya and review of the African literature	9
Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis	9
Changes over time in inflammatory and structural lesions at the sacroiliac joint in children with spondyloarthritis exposed and unexposed to tumor necrosis factor inhibitor	9
Axial involvement in enthesitis-related arthritis: results from a single-center cohort	8
Comment on: homozygous variant p. Arg90His in NCF1 is associated with early-onset interferonopathy: a case report	8
Assay for interferon gamma release as a novel marker in pediatric patients with systemic lupus erythematosus	8
MicroRNA-27a-3p enhances the inflammatory phenotype of Juvenile Idiopathic Arthritis fibroblast-like synoviocytes	8
Bone health and physical activity in adolescents with juvenile idiopathic arthritis: a cross-sectional case-control study	8
Capillary microscopy is a potential screening method for connective tissue disease in children with Raynaud’s phenomenon	8
High prevalence of sacroiliitis and early structural changes in the sacroiliac joint in children with enthesitis-related arthritis: findings from a tertiary centre in Hong Kong	8
Scurvy masquerading as IgA vasculitis	8
Whole-exome sequencing analysis identifies novel variants associated with Kawasaki disease susceptibility	8
Changes in total body fat and body mass index among children with juvenile dermatomyositis treated with high-dose glucocorticoids	8
Characterizing lupus in African American children in Southern United States	8
Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis	8
Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report	7
Pain-coping scale for children and their parents: a cross-sectional study in children with musculoskeletal pain	7
Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination	7
Towards a histological diagnosis of childhood small vessel CNS vasculitis	7
Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data	7
Paediatric autoimmune diseases with ELANE mutations associated with neutropenia	7
Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series	7
Panniculitis with late onset enthesitis-related arthritis: a case report	7
Transition readiness in adolescents and young adults with chronic rheumatic disease in Oman: today’s needs and future challenges	7
Feasibility of applying infrared thermal imaging for home monitoring of arthritis in children	7
ANCA-negative eosinophilic granulomatosis with polyangiitis in a girl misdiagnosed as asthma and pulmonary tuberculosis	7
Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe	7
Musculoskeletal involvement in childhood leukemia: Characteristics and survival outcomes	7
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE	7
Is an association of acro-osteolysis, bone fragility, and enchondromatosis a newfound disease caused by an amplification of PTHLH? A case report	7
Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research	7
Correction: Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases	7
High rheumatoid factor does not diminish efficacy of TNF inhibitors in seropositive JIA	7
Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors	7
Unveiling the uncommon: diagnostic journey of camurati-engelmann disease in a pediatric patient	7
Infections and antibiotics during fetal life and childhood and their relationship to juvenile idiopathic arthritis: a prospective cohort study	7
PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	6
An updated overview of Juvenile systemic sclerosis in a French cohort	6
What have we learned from long-term studies in juvenile idiopathic arthritis? – Prediction, classification, transition.	6
Blau syndrome: a case report from Palestine	6
Bacterial infection in patients with juvenile systemic lupus erythematosus and fever	6
Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study	6
Effect of exercise training on heath, quality of life, exercise capacity in juvenile idiopathic arthritis: a meta-analysis of randomized controlled trials	6
Prevalence of spine pain among Tunisian children and adolescents and related factors	6
Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort	6
Musculoskeletal pain and its effect on daily activity and behaviour in Icelandic children and youths with juvenile idiopathic arthritis: a cross-sectional case-control study	6
Accuracy and adequacy of photoprotection in pediatric systemic lupus erythematosus patients, and the effect of education on photoprotection: a prospective study	6
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis	6
Kawasaki disease with an asymptomatic reversible splenial lesion	6
Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry	6
Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease	6
A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature	6
Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype	5
Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study	5
A mixed-method systematic review evaluating interventions in paediatric rheumatology to address caregiver support and well-being	5
A case report of a severe neonatal systemic vasculitis on the first day of life	5
Kawasaki disease in neonates: a case report and literature review	5
A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children wit	5
Quality improvement in juvenile idiopathic arthritis: a mixed-methods implementation pilot of the CAPTURE-JIA dataset	5
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry	5
Publisher Correction: Musculoskeletal involvement in childhood leukemia: Characteristics and survival outcomes	5
Novel multiple Z-score models for detection of coronary artery dilation: application in Kawasaki disease	5
Nailfold videocapillaroscopy in patients with deficiency of adenosine deaminase 2 (DADA2): a case-control study	5
Correction: Engaging patients and parents to improve mental health intervention for youth with rheumatological disease	5
Favorable outcomes with reduced steroid use in juvenile dermatomyositis	5
Aquaporin-4 IgG antibodies: predictors of positivity and their relationship with neuropsychiatric disorders and white matter lesions in Juvenile systemic lupus erythematosus	5
Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis	5
Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity	5
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis	5
Serine, N-acetylaspartate differentiate adolescents with juvenile idiopathic arthritis compared with healthy controls: a metabolomics cross-sectional study	5
Biologic medicine inclusion in 138 national essential medicines lists	5

A novel frameshift variant in the ADA2 gene of a patient with a neurological phenotype: a case report	5
“I’d like more options!”: Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritis	5
Proceedings of the 2024 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting	5
Synchronous disease onset and flares in siblings with PFAPA	5
The 4th NextGen therapies of SJIA and MAS, part 4: it is time for IL-18 based trials in systemic juvenile idiopathic arthritis?	5
Increased vascular deposition of oxidized LDL in untreated juvenile dermatomyositis	5
Clinical characteristics and prognosis of interstitial lung disease in systemic juvenile idiopathic arthritis: a two-center retrospective observational cohort study	5
Juvenile diabetes and systemic sclerosis: just a coincidence?	5
Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach	5
Economic impact of Juvenile Idiopathic Arthritis: a systematic review	5
Th17/1 and ex-Th17 cells are detected in patients with polyarticular juvenile arthritis and increase following treatment	5
Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study	5
The use of ECMO in pediatric granulomatosis with polyangiitis	4
International multidisciplinary consensus on the definition and clinical approach for monogenic inflammatory immune dysregulation disorders	4
Clinical observations on infliximab treatment of infantile onset Takayasu arteritis	4
Perspectives and experiences of parents of children with juvenile dermatomyositis: a semi-structured interview study	4
Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients	4
Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease	4
Colchicine treatment can be discontinued in a selected group of pediatric FMF patients	4
Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates	4
Revising the WHO Essential Medicines List for paediatric rheumatology update	4
Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study	4
The relationships of kinesiophobia and physical function and physical activity level in juvenile idiopathic arthritis	4
Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study	4
The effect of TNF treatment uptake on incident hospital admission in Western Australia	4
Lymphocyte apoptosis and its association with the inflammatory markers and disease severity in juvenile-onset systemic lupus erythematosus patients	4
Reverse complete heart block using transcutaneous pacing and repeated plasmapheresis in a neonate with lupus: a case report	4
Rheumatic fever in a developed country – is it still relevant? A retrospective, 25 years follow-up	4
Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East	4
α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis	4
Juvenile eosinophilic fasciitis: a single center case series	4
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series	4
Correction: Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study	4
A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list	4
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset	4
Longitudinal follow-up of mixed connective tissue disease and overlapping autoimmune diseases of childhood onset in the Afro-descendant population of the French West Indies	4
Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM)	4
Aicardi-Goutières syndrome type 6: report of ADAR variant and clinical outcome after ruxolitinib treatment in the neonatal period	4
The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study	4
A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice	4
Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata	4
Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry	4
A tale of two regions: comparing clinical features and outcomes in pediatric enthesitis-related arthritis	4
Clinical features of Kawasaki disease initially mimicking retropharyngeal abscess: a retrospective analysis	4
Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report	4
“Online survey of COVID-19 immunization and infection in patients with systemic juvenile idiopathic arthritis and adult-onset still’s disease.”	4
Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing	4
The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA	4
Monoarticular juvenile idiopathic arthritis as a distinct clinical entity A proof-of-concept study	4
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy	3
Intra-articular venous malformations of the knee: a diagnostic challenge	3
Shaping the future of pediatric rheumatology	3
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay	3
Retropharyngeal abscess-like as an atypical presentation of Kawasaki disease: a case report and literature review	3
Clinical characteristics and risk factors of coronary artery lesions in chinese pediatric Takayasu arteritis patients: a retrospective study	3
Giant bilateral axillary artery aneurysms with left complete obstructive thrombus in intravenous immunoglobulin-sensitive Kawasaki disease: a case report	3
Proceedings from the 4th NextGen Therapies for SJIA and MAS virtual symposium held February 13–14, 2022	3
Latent classes of early response trajectories to biologics initiation in juvenile idiopathic arthritis: an analysis of four trials	3
Cardiac repolarization abnormalities in children with familial Mediterranean fever	3
Resilience and its associations in children with Systemic Lupus Erythematosus and Juvenile Idiopathic Arthritis	3
Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatment	3
Targeted provider education and pre-visit planning increase rates of formal depression screening in childhood-onset SLE	3
Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices	3
Lack of HLH in FMF	3
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans	3
Correction to: Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing	3
Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience	3
Pulmonary manifestations of childhood-onset primary Sjogren’s syndrome (SS) masquerading as reactive airways disease in a male patient and review of interstitial lung disease associated with SS	3
Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis	3
Antibodies to histone in the pediatric population: a retrospective chart review	3
Provider assessment of the temporomandibular joint in Juvenile idiopathic arthritis: a retrospective analysis from the CARRA database	3
Long-term growth and final adult height outcome in childhood-onset systemic lupus erythematosus	3
Kawasaki disease complicated by peripheral artery thrombosis: a case report and literature review	3
Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review	3
Resource utilization and costs of transitioning from pediatric to adult care for patients with chronic autoinflammatory and autoimmune disorders	3
Successful experience of tofacitinib treatment in patients with Fibrodysplasia Ossificans Progressiva	3
Tocilizumab for massive refractory pleural effusion in an adolescent with systemic lupus erythematosus	3
A Chinese child with both systemic lupus erythematosus coexisting with neuromyelitis optica spectrum disorder: a case report	3
Impact of physiotherapy on orofacial manifestations of juvenile idiopathic arthritis	3
Causal relationship between serum metabolites and juvenile idiopathic arthritis: a mendelian randomization study	3
Significance of differential diagnosis for the elucidation of rare and complicated diseases	3
Treat-to-target strategies for the management of familial Mediterranean Fever in children	3
Identifying circRNA-associated-ceRNA networks in juvenile spondyloarthropathies patients	3
Efficacy of mycophenolate mofetil for the maintenance therapy of anti-AQP4 antibody-positive NMOSD complying with probable sjögren’s disease in a 2-year-old girl: a case report	3
The utility of miR-16, miR-146a and miR-155 in serum and urine for juvenile idiopathic arthritis diagnostics and monitoring	3
Bridging gaps: a qualitative inquiry on improving paediatric rheumatology care among healthcare workers in Kenya	3
Unmet needs and research gaps in Still’s disease across ages: proceedings from a pediatric and adult joint expert panel	3
Correction: Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry	2
Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)	2
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab	2
Influenza vaccination in patients with juvenile idiopathic arthritis under different treatments: safety and immune response	2
Unravelling the clinical heterogeneity of undefined recurrent fever over time in the European registries on Autoinflammation	2
Colchicine – an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants	2
TNFAIP3 mutation causing haploinsufficiency of A20 with a hemophagocytic lymphohistiocytosis phenotype: a report of two cases	2
IgG4 related pericardium and lung disease in pediatric patient complicated with fatal massive hemoptysis: a case report and review of literature	2